We are live on ! Find out more
BCAM

Boston Common Asset Management Portfolio holdings

AUM $1.69B
1-Year Est. Return 28.29%
This Fund
S&P 500
This Quarter Est. Return
+6.44%
1 Year Est. Return
+28.29%
3 Year Est. Return
+54.94%
5 Year Est. Return
+54.02%
10 Year Est. Return
+260.31%
AUM
$3.57B
AUM Growth
+$273M
Cap. Flow
-$19.8M
Cap. Flow %
-0.56%
Top 10 Hldgs %
15.41%
Holding
325
New
35
Increased
82
Reduced
162
Closed
28

Top Buys

Rank Stock Value
1
DGX icon
Quest Diagnostics
DGX
+$12.9M
2
CRM icon
Salesforce
CRM
+$9.6M
3
TSM icon
TSMC
TSM
+$9.22M
4
KLAC icon
KLA
KLAC
+$7.93M
5
LLY icon
Eli Lilly
LLY
+$6.58M

Sector Composition

Rank Sector Weight
1 Technology 13.67%
2 Financials 8.72%
3 Healthcare 5.78%
4 Communication Services 4.95%
5 Industrials 4.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TSM icon
1
TSMC
TSM
$2.09T
$102M 2.87%
452,284
+49,756
+12% +$9.22M
MSFT icon
2
Microsoft
MSFT
$2.84T
$75.3M 2.11%
151,459
-4,409
-3% -$1.91M
NVDA icon
3
NVIDIA
NVDA
$5.01T
$63.6M 1.78%
402,248
+34,379
+9% +$4.33M
AAPL icon
4
Apple
AAPL
$4.89T
$51M 1.43%
248,521
-6,315
-2% -$1.28M
NFLX icon
5
Netflix
NFLX
$292B
$46.5M 1.3%
347,610
-20,580
-6% -$2.33M
AVGO icon
6
Broadcom
AVGO
$1.82T
$40.9M 1.15%
148,541
-10,359
-7% -$2.25M
HDB icon
7
HDFC Bank
HDB
$119B
$34.6M 0.97%
903,716
+49,486
+6% +$1.79M
GOOGL icon
8
Alphabet (Google) Class A
GOOGL
$3.91T
$34.1M 0.96%
193,376
+22,947
+13% +$3.76M
V icon
9
Visa
V
$677B
$33.3M 0.93%
93,661
-6,870
-7% -$2.39M
MS icon
10
Morgan Stanley
MS
$337B
$31.8M 0.89%
226,009
-2,363
-1% -$290K
CRM icon
11
Salesforce
CRM
$134B
$31.7M 0.89%
116,177
+35,918
+45% +$9.6M
AZN icon
12
AstraZeneca
AZN
$263B
$30.1M 0.85%
125,889
-2,935
-2% -$411K
GOOG icon
13
Alphabet (Google) Class C
GOOG
$3.9T
$27.9M 0.78%
157,547
-2,389
-1% -$395K
LLY icon
14
Eli Lilly
LLY
$1.07T
$27.9M 0.78%
35,763
+8,468
+31% +$6.58M
CL icon
15
Colgate-Palmolive
CL
$72.6B
$27.5M 0.77%
302,551
+6,572
+2% +$600K
TMUS icon
16
T-Mobile US
TMUS
$193B
$24.4M 0.68%
102,357
-9,608
-9% -$2.35M
AWK icon
17
American Water Works
AWK
$26.3B
$24.2M 0.68%
173,684
+15,589
+10% +$2.23M
BKNG icon
18
Booking.com
BKNG
$138B
$24M 0.67%
103,650
+4,275
+4% +$875K
VZ icon
19
Verizon
VZ
$194B
$23.8M 0.67%
551,019
+83,930
+18% +$3.63M
CRH icon
20
CRH
CRH
$66.7B
$23.7M 0.66%
257,803
-26,899
-9% -$2.45M
TJX icon
21
TJX Companies
TJX
$170B
$23.3M 0.65%
188,694
-7,787
-4% -$988K
CB icon
22
Chubb
CB
$140B
$22.2M 0.62%
76,673
-10,908
-12% -$3.14M
WAB icon
23
Wabtec
WAB
$51.1B
$21.5M 0.6%
102,484
-20,253
-17% -$3.89M
MRK icon
24
Merck
MRK
$324B
$21.4M 0.6%
269,727
-30,618
-10% -$2.43M
VRTX icon
25
Vertex Pharmaceuticals
VRTX
$121B
$20.5M 0.57%
46,063
-4,900
-10% -$2.26M

Similar funds

Boston Common Asset Management's Q2 2025 Portfolio in Review

As of Q2 2025, Boston Common Asset Management held 325 positions worth $3.57B, up 8.3% from $3.29B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Boston Common Asset Management's Q2 2025 filing shows 35 new, 82 increased, 162 reduced and 28 closed positions. Its largest new stake was Quest Diagnostics: 74,250 shares worth $13.3M. The largest sale was Regeneron Pharmaceuticals, an estimated $17.3M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.

  • Boston Common Asset Management's largest Q2 2025 buy was Quest Diagnostics: 74,250 shares worth $13.3M.
  • Boston Common Asset Management added most to Salesforce in Q2 2025, an estimated $9.6M increase.
  • Boston Common Asset Management's biggest Q2 2025 reduction was Micron Technology, cutting an estimated $10M.
  • Boston Common Asset Management fully exited Regeneron Pharmaceuticals in Q2 2025, selling an estimated $17.3M.
  • Boston Common Asset Management's ten largest holdings make up 15% of its $3.57B portfolio in Q2 2025.
  • Boston Common Asset Management opened 35 new positions and closed 28 in Q2 2025.
  • Boston Common Asset Management's portfolio value rose 8.3% quarter-over-quarter to $3.57B.

Based on Boston Common Asset Management's 13F filing for Q2 2025, filed 22 Jul 2025.